# Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain

> **NCT01902524** · PHASE4 · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 65 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** Fentanyl-TTS

## Key facts

- **NCT ID:** NCT01902524
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2014-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01902524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01902524, "Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01902524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*